MPO and clostridium difficile infection: Mice treated with pooled microbiotherapy or with products from single donors 4 and 5 showed significantly lower colonic inflammation, with median MPO levels at least five times below those of the CD group (<300 ng/g; P < 0.005), in line with the CDI model description in the literature (44, 52).